NCT02523703View on ClinicalTrials.gov

Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 10, 2007

Primary Completion Date

February 15, 2012

Study Completion Date

February 23, 2015

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

glutamate and aspartate

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT02523703 - Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study | Biotech Hunter | Biotech Hunter